| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA7
|
ATP-binding cassette, sub-family A (ABC1), member 7
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCE1
|
ATP-binding cassette, sub-family E (OABP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABCG5
|
ATP-binding cassette, sub-family G (WHITE), member 5
|
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8
|
|
ABLIM1
|
actin binding LIM protein 1
|
|
ACACB
|
acetyl-CoA carboxylase beta
|
|
ACAD9
|
acyl-CoA dehydrogenase family, member 9
|
|
ACADSB
|
acyl-CoA dehydrogenase, short/branched chain
|
|
ACAN
|
aggrecan
|
|
ACBD3
|
acyl-CoA binding domain containing 3
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADA
|
adenosine deaminase
|
|
ADAM29
|
ADAM metallopeptidase domain 29
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADARB1
|
adenosine deaminase, RNA-specific, B1
|
|
ADCY8
|
adenylate cyclase 8 (brain)
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADH5
|
alcohol dehydrogenase 5 (class III), chi polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADM
|
adrenomedullin
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHNAK
|
AHNAK nucleoprotein
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIM2
|
absent in melanoma 2
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AIRE
|
autoimmune regulator
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
AKR1B15
|
aldo-keto reductase family 1, member B15
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMFR
|
autocrine motility factor receptor, E3 ubiquitin protein ligase
|
|
AMH
|
anti-Mullerian hormone
|
|
AMY1A
|
amylase, alpha 1A (salivary)
|
|
AMY1B
|
amylase, alpha 1B (salivary)
|
|
AMY1C
|
amylase, alpha 1C (salivary)
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
ANKRD30A
|
ankyrin repeat domain 30A
|
|
ANO2
|
anoctamin 2, calcium activated chloride channel
|
|
ANO9
|
anoctamin 9
|
|
ANXA1
|
annexin A1
|
|
ANXA11
|
annexin A11
|
|
ANXA2
|
annexin A2
|
|
ANXA4
|
annexin A4
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APEX2
|
APEX nuclease (apurinic/apyrimidinic endonuclease) 2
|
|
APLN
|
apelin
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA2
|
apolipoprotein A-II
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3A
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A
|
|
APOBEC3C
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOBEC3H
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H
|
|
APOBR
|
apolipoprotein B receptor
|
|
APOD
|
apolipoprotein D
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APOL1
|
apolipoprotein L, 1
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP4
|
aquaporin 4
|
|
AQP5
|
aquaporin 5
|
|
AR
|
androgen receptor
|
|
ARAF
|
A-Raf proto-oncogene, serine/threonine kinase
|
|
ARC
|
activity-regulated cytoskeleton-associated protein
|
|
AREG
|
amphiregulin
|
|
ARHGAP29
|
Rho GTPase activating protein 29
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARRB2
|
arrestin, beta 2
|
|
AS3MT
|
arsenite methyltransferase
|
|
ASIP
|
agouti signaling protein
|
|
ASPM
|
asp (abnormal spindle) homolog, microcephaly associated (Drosophila)
|
|
ATF2
|
activating transcription factor 2
|
|
ATG7
|
autophagy related 7
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP13A2
|
ATPase type 13A2
|
|
ATP1B2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide
|
|
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
|
|
ATXN1
|
ataxin 1
|
|
ATXN2
|
ataxin 2
|
|
ATXN3
|
ataxin 3
|
|
ATXN7L3
|
ataxin 7-like 3
|
|
AURKA
|
aurora kinase A
|
|
AXIN2
|
axin 2
|
|
B2M
|
beta-2-microglobulin
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BANK1
|
B-cell scaffold protein with ankyrin repeats 1
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCAR4
|
breast cancer anti-estrogen resistance 4 (non-protein coding)
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BET1L
|
Bet1 golgi vesicular membrane trafficking protein-like
|
|
BGN
|
biglycan
|
|
BHLHA15
|
basic helix-loop-helix family, member a15
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTAF1
|
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa
|
|
BTNL2
|
butyrophilin-like 2
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
C1QC
|
complement component 1, q subcomponent, C chain
|
|
C2
|
complement component 2
|
|
C3
|
complement component 3
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
C4BPA
|
complement component 4 binding protein, alpha
|
|
C5AR1
|
complement component 5a receptor 1
|
|
C7
|
complement component 7
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CA2
|
carbonic anhydrase II
|
|
CA9
|
carbonic anhydrase IX
|
|
CAB39L
|
calcium binding protein 39-like
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CADM1
|
cell adhesion molecule 1
|
|
CALB1
|
calbindin 1, 28kDa
|
|
CALB2
|
calbindin 2
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CAMTA1
|
calmodulin binding transcription activator 1
|
|
CAPG
|
capping protein (actin filament), gelsolin-like
|
|
CASC5
|
cancer susceptibility candidate 5
|
|
CASP14
|
caspase 14, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBR4
|
carbonyl reductase 4
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL14
|
chemokine (C-C motif) ligand 14
|
|
CCL16
|
chemokine (C-C motif) ligand 16
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD14
|
CD14 molecule
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD163
|
CD163 molecule
|
|
CD180
|
CD180 molecule
|
|
CD1B
|
CD1b molecule
|
|
CD1C
|
CD1c molecule
|
|
CD1D
|
CD1d molecule
|
|
CD24
|
CD24 molecule
|
|
CD320
|
CD320 molecule
|
|
CD34
|
CD34 molecule
|
|
CD37
|
CD37 molecule
|
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex)
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
|
CD80
|
CD80 molecule
|
|
CD81
|
CD81 molecule
|
|
CD83
|
CD83 molecule
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKAL1
|
CDK5 regulatory subunit associated protein 1-like 1
|
|
CDKL3
|
cyclin-dependent kinase-like 3
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDSN
|
corneodesmosin
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CENPA
|
centromere protein A
|
|
CEP152
|
centrosomal protein 152kDa
|
|
CEP55
|
centrosomal protein 55kDa
|
|
CERS2
|
ceramide synthase 2
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFB
|
complement factor B
|
|
CFH
|
complement factor H
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFP
|
complement factor properdin
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHD5
|
chromodomain helicase DNA binding protein 5
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
|
CHD8
|
chromodomain helicase DNA binding protein 8
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHKB
|
choline kinase beta
|
|
CHM
|
choroideremia (Rab escort protein 1)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CIZ1
|
CDKN1A interacting zinc finger protein 1
|
|
CKLF
|
chemokine-like factor
|
|
CKM
|
creatine kinase, muscle
|
|
CLDN1
|
claudin 1
|
|
CLDN3
|
claudin 3
|
|
CLDN5
|
claudin 5
|
|
CLDN7
|
claudin 7
|
|
CLN3
|
ceroid-lipofuscinosis, neuronal 3
|
|
CLU
|
clusterin
|
|
CMA1
|
chymase 1, mast cell
|
|
CNOT8
|
CCR4-NOT transcription complex, subunit 8
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNTNAP2
|
contactin associated protein-like 2
|
|
COA6
|
cytochrome c oxidase assembly factor 6
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
COMT
|
catechol-O-methyltransferase
|
|
CORO1C
|
coronin, actin binding protein, 1C
|
|
CPT1A
|
carnitine palmitoyltransferase 1A (liver)
|
|
CPT1B
|
carnitine palmitoyltransferase 1B (muscle)
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRISP3
|
cysteine-rich secretory protein 3
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAB
|
crystallin, alpha B
|
|
CRYBB1
|
crystallin, beta B1
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSNK1D
|
casein kinase 1, delta
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CST3
|
cystatin C
|
|
CST6
|
cystatin E/M
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTDSP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND2
|
catenin (cadherin-associated protein), delta 2
|
|
CTSB
|
cathepsin B
|
|
CTSG
|
cathepsin G
|
|
CTSH
|
cathepsin H
|
|
CTSK
|
cathepsin K
|
|
CTSL
|
cathepsin L
|
|
CTTN
|
cortactin
|
|
CUL5
|
cullin 5
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2R1
|
cytochrome P450, family 2, subfamily R, polypeptide 1
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP46A1
|
cytochrome P450, family 46, subfamily A, polypeptide 1
|
|
CYP7B1
|
cytochrome P450, family 7, subfamily B, polypeptide 1
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAXX
|
death-domain associated protein
|
|
DAZ1
|
deleted in azoospermia 1
|
|
DAZL
|
deleted in azoospermia-like
|
|
DBF4
|
DBF4 zinc finger
|
|
DCDC2
|
doublecortin domain containing 2
|
|
DCT
|
dopachrome tautomerase
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
|
DDR1
|
discoidin domain receptor tyrosine kinase 1
|
|
DDX11
|
DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEFB104A
|
defensin, beta 104A
|
|
DEFB104B
|
defensin, beta 104B
|
|
DEFB106A
|
defensin, beta 106A
|
|
DEFB4A
|
defensin, beta 4A
|
|
DES
|
desmin
|
|
DFNA5
|
deafness, autosomal dominant 5
|
|
DGKH
|
diacylglycerol kinase, eta
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKK2
|
dickkopf WNT signaling pathway inhibitor 2
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLGAP5
|
discs, large (Drosophila) homolog-associated protein 5
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DLST
|
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex)
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DMD
|
dystrophin
|
|
DNAJB4
|
DnaJ (Hsp40) homolog, subfamily B, member 4
|
|
DNAJC7
|
DnaJ (Hsp40) homolog, subfamily C, member 7
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPT
|
dermatopontin
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DSG1
|
desmoglein 1
|
|
DSG2
|
desmoglein 2
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
DYRK3
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3
|
|
DYSF
|
dysferlin
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F3
|
E2F transcription factor 3
|
|
EARS2
|
glutamyl-tRNA synthetase 2, mitochondrial
|
|
EBP
|
emopamil binding protein (sterol isomerase)
|
|
ECD
|
ecdysoneless homolog (Drosophila)
|
|
EDA
|
ectodysplasin A
|
|
EDAR
|
ectodysplasin A receptor
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
|
EFEMP2
|
EGF containing fibulin-like extracellular matrix protein 2
|
|
EFNA5
|
ephrin-A5
|
|
EGF
|
epidermal growth factor
|
|
EGFLAM
|
EGF-like, fibronectin type III and laminin G domains
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
|
EGR1
|
early growth response 1
|
|
EHD1
|
EH-domain containing 1
|
|
EIF5A
|
eukaryotic translation initiation factor 5A
|
|
ELAC2
|
elaC ribonuclease Z 2
|
|
ELN
|
elastin
|
|
EMILIN1
|
elastin microfibril interfacer 1
|
|
EMP3
|
epithelial membrane protein 3
|
|
EN1
|
engrailed homeobox 1
|
|
ENG
|
endoglin
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPO
|
erythropoietin
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESM1
|
endothelial cell-specific molecule 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRG
|
estrogen-related receptor gamma
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
EVPL
|
envoplakin
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F10
|
coagulation factor X
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FABP1
|
fatty acid binding protein 1, liver
|
|
FABP3
|
fatty acid binding protein 3, muscle and heart
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FADS1
|
fatty acid desaturase 1
|
|
FADS2
|
fatty acid desaturase 2
|
|
FAM134B
|
family with sequence similarity 134, member B
|
|
FAM167A
|
family with sequence similarity 167, member A
|
|
FAM168A
|
family with sequence similarity 168, member A
|
|
FAM53B
|
family with sequence similarity 53, member B
|
|
FAM65B
|
family with sequence similarity 65, member B
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FBLN5
|
fibulin 5
|
|
FBN1
|
fibrillin 1
|
|
FBP2
|
fructose-1,6-bisphosphatase 2
|
|
FBXO11
|
F-box protein 11
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FCN3
|
ficolin (collagen/fibrinogen domain containing) 3
|
|
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I)
|
|
FGA
|
fibrinogen alpha chain
|
|
FGB
|
fibrinogen beta chain
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FGG
|
fibrinogen gamma chain
|
|
FHIT
|
fragile histidine triad
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLG
|
filaggrin
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLNC
|
filamin C, gamma
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXC1
|
forkhead box C1
|
|
FOXF1
|
forkhead box F1
|
|
FOXL2
|
forkhead box L2
|
|
FOXM1
|
forkhead box M1
|
|
FOXP1
|
forkhead box P1
|
|
FOXP2
|
forkhead box P2
|
|
FOXP3
|
forkhead box P3
|
|
FRZB
|
frizzled-related protein
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FTMT
|
ferritin mitochondrial
|
|
FTO
|
fat mass and obesity associated
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FUT8
|
fucosyltransferase 8 (alpha (1,6) fucosyltransferase)
|
|
FXN
|
frataxin
|
|
FZD10
|
frizzled class receptor 10
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GAK
|
cyclin G associated kinase
|
|
GALNT3
|
polypeptide N-acetylgalactosaminyltransferase 3
|
|
GAP43
|
growth associated protein 43
|
|
GATA3
|
GATA binding protein 3
|
|
GBA
|
glucosidase, beta, acid
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GCGR
|
glucagon receptor
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF5
|
growth differentiation factor 5
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GFRA1
|
GDNF family receptor alpha 1
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIT1
|
G protein-coupled receptor kinase interacting ArfGAP 1
|
|
GJA5
|
gap junction protein, alpha 5, 40kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLRX2
|
glutaredoxin 2
|
|
GM2A
|
GM2 ganglioside activator
|
|
GNAS
|
GNAS complex locus
|
|
GNB1
|
guanine nucleotide binding protein (G protein), beta polypeptide 1
|
|
GOLGA3
|
golgin A3
|
|
GPBAR1
|
G protein-coupled bile acid receptor 1
|
|
GPNMB
|
glycoprotein (transmembrane) nmb
|
|
GPR68
|
G protein-coupled receptor 68
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GPX3
|
glutathione peroxidase 3
|
|
GPX4
|
glutathione peroxidase 4
|
|
GRAP2
|
GRB2-related adaptor protein 2
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRIK4
|
glutamate receptor, ionotropic, kainate 4
|
|
GRN
|
granulin
|
|
GRP
|
gastrin-releasing peptide
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GSTZ1
|
glutathione S-transferase zeta 1
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAS1
|
hyaluronan synthase 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBB
|
hemoglobin, beta
|
|
HBG2
|
hemoglobin, gamma G
|
|
HCFC1
|
host cell factor C1
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HELLS
|
helicase, lymphoid-specific
|
|
HERC5
|
HECT and RLD domain containing E3 ubiquitin protein ligase 5
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIP1
|
huntingtin interacting protein 1
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-F
|
major histocompatibility complex, class I, F
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HLCS
|
holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase)
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPL
|
heterogeneous nuclear ribonucleoprotein L
|
|
HOXC13
|
homeobox C13
|
|
HP
|
haptoglobin
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HPSE
|
heparanase
|
|
HPX
|
hemopexin
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD17B7
|
hydroxysteroid (17-beta) dehydrogenase 7
|
|
HSD17B8
|
hydroxysteroid (17-beta) dehydrogenase 8
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA1L
|
heat shock 70kDa protein 1-like
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HYAL1
|
hyaluronoglucosaminidase 1
|
|
IBD5
|
inflammatory bowel disease 5
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA8
|
interferon, alpha 8
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNL1
|
interferon, lambda 1
|
|
IFNL3
|
interferon, lambda 3
|
|
IFT74
|
intraflagellar transport 74
|
|
IGBP1
|
immunoglobulin (CD79A) binding protein 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos)
|
|
IL10
|
interleukin 10
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
|
IL13
|
interleukin 13
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
|
IL17A
|
interleukin 17A
|
|
IL17F
|
interleukin 17F
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL23R
|
interleukin 23 receptor
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL32
|
interleukin 32
|
|
IL33R
|
interleukin 33 receptor
|
|
IL36R
|
interleukin 36 receptor
|
|
IL37
|
interleukin 37
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL4
|
interleukin 4
|
|
IL4I1
|
interleukin 4 induced 1
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9
|
interleukin 9
|
|
ILK
|
integrin-linked kinase
|
|
INHA
|
inhibin, alpha
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF6
|
interferon regulatory factor 6
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB4
|
integrin, beta 4
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
JAM3
|
junctional adhesion molecule 3
|
|
JUN
|
jun proto-oncogene
|
|
JUP
|
junction plakoglobin
|
|
KAT7
|
K(lysine) acetyltransferase 7
|
|
KATNAL2
|
katanin p60 subunit A-like 2
|
|
KCNB1
|
potassium channel, voltage gated Shab related subfamily B, member 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNN2
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ3
|
potassium channel, voltage gated KQT-like subfamily Q, member 3
|
|
KCNQ4
|
potassium channel, voltage gated KQT-like subfamily Q, member 4
|
|
KDM4C
|
lysine (K)-specific demethylase 4C
|
|
KDM5A
|
lysine (K)-specific demethylase 5A
|
|
KDR
|
kinase insert domain receptor
|
|
KHSRP
|
KH-type splicing regulatory protein
|
|
KIAA0319
|
KIAA0319
|
|
KIAA0391
|
KIAA0391
|
|
KIAA0556
|
KIAA0556
|
|
KIF18A
|
kinesin family member 18A
|
|
KIF2C
|
kinesin family member 2C
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLC1
|
kinesin light chain 1
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLK1
|
kallikrein 1
|
|
KLK10
|
kallikrein-related peptidase 10
|
|
KLK11
|
kallikrein-related peptidase 11
|
|
KLK13
|
kallikrein-related peptidase 13
|
|
KLK14
|
kallikrein-related peptidase 14
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK5
|
kallikrein-related peptidase 5
|
|
KLK6
|
kallikrein-related peptidase 6
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KLK8
|
kallikrein-related peptidase 8
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT17
|
keratin 17, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRT20
|
keratin 20, type I
|
|
KRT7
|
keratin 7, type II
|
|
KRT8
|
keratin 8, type II
|
|
KRT9
|
keratin 9, type I
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAMC2
|
laminin, gamma 2
|
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta
|
|
LCE2B
|
late cornified envelope 2B
|
|
LCN2
|
lipocalin 2
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LCT
|
lactase
|
|
LDHA
|
lactate dehydrogenase A
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LIPC
|
lipase, hepatic
|
|
LIPG
|
lipase, endothelial
|
|
LMO1
|
LIM domain only 1 (rhombotin 1)
|
|
LMOD2
|
leiomodin 2 (cardiac)
|
|
LOR
|
loricrin
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPAL2
|
lipoprotein, Lp(a)-like 2, pseudogene
|
|
LPCAT2
|
lysophosphatidylcholine acyltransferase 2
|
|
LPL
|
lipoprotein lipase
|
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LRSAM1
|
leucine rich repeat and sterile alpha motif containing 1
|
|
LTA
|
lymphotoxin alpha
|
|
LTA4H
|
leukotriene A4 hydrolase
|
|
LTB
|
lymphotoxin beta (TNF superfamily, member 3)
|
|
LTBP1
|
latent transforming growth factor beta binding protein 1
|
|
LUM
|
lumican
|
|
LY6D
|
lymphocyte antigen 6 complex, locus D
|
|
LYRM4
|
LYR motif containing 4
|
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B
|
|
MAGEA4
|
melanoma antigen family A4
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAP1LC3A
|
microtubule-associated protein 1 light chain 3 alpha
|
|
MAP2
|
microtubule-associated protein 2
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARK4
|
MAP/microtubule affinity-regulating kinase 4
|
|
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)
|
|
MASP2
|
mannan-binding lectin serine peptidase 2
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC2R
|
melanocortin 2 receptor (adrenocorticotropic hormone)
|
|
MC3R
|
melanocortin 3 receptor
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCPH1
|
microcephalin 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEFV
|
Mediterranean fever
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFI2
|
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICAL1
|
microtubule associated monooxygenase, calponin and LIM domain containing 1
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR100
|
microRNA 100
|
|
MIR10A
|
microRNA 10a
|
|
MIR122
|
microRNA 122
|
|
MIR126
|
microRNA 126
|
|
MIR130A
|
microRNA 130a
|
|
MIR146A
|
microRNA 146a
|
|
MIR155
|
microRNA 155
|
|
MIR17
|
microRNA 17
|
|
MIR193B
|
microRNA 193b
|
|
MIR20A
|
microRNA 20a
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR22
|
microRNA 22
|
|
MIR223
|
microRNA 223
|
|
MIR29A
|
microRNA 29a
|
|
MIR326
|
microRNA 326
|
|
MIR328
|
microRNA 328
|
|
MIR9-1
|
microRNA 9-1
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLANA
|
melan-A
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP10
|
matrix metallopeptidase 10
|
|
MMP11
|
matrix metallopeptidase 11
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPO
|
myeloperoxidase
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MRPL4
|
mitochondrial ribosomal protein L4
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MSH6
|
mutS homolog 6
|
|
MSLN
|
mesothelin
|
|
MSMB
|
microseminoprotein, beta-
|
|
MSRB1
|
methionine sulfoxide reductase B1
|
|
MSRB2
|
methionine sulfoxide reductase B2
|
|
MST1
|
macrophage stimulating 1
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MSTN
|
myostatin
|
|
MSX1
|
msh homeobox 1
|
|
MT-TI
|
tRNA
|
|
MTCH1
|
mitochondrial carrier 1
|
|
MTDH
|
metadherin
|
|
MTHFD1L
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTM1
|
myotubularin 1
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTRNR2L1
|
MT-RNR2-like 1
|
|
MTRNR2L10
|
MT-RNR2-like 10
|
|
MTRNR2L2
|
MT-RNR2-like 2
|
|
MTRNR2L3
|
MT-RNR2-like 3
|
|
MTRNR2L4
|
MT-RNR2-like 4
|
|
MTRNR2L5
|
MT-RNR2-like 5
|
|
MTRNR2L6
|
MT-RNR2-like 6
|
|
MTRNR2L7
|
MT-RNR2-like 7
|
|
MTRNR2L8
|
MT-RNR2-like 8
|
|
MTRNR2L9
|
MT-RNR2-like 9
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC15
|
mucin 15, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
MUCL1
|
mucin-like 1
|
|
MUM1
|
melanoma associated antigen (mutated) 1
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MYBBP1A
|
MYB binding protein (P160) 1a
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
MYT1L
|
myelin transcription factor 1-like
|
|
NABP2
|
nucleic acid binding protein 2
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NANOG
|
Nanog homeobox
|
|
NAPSA
|
napsin A aspartic peptidase
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBEA
|
neurobeachin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOA6
|
nuclear receptor coactivator 6
|
|
NDEL1
|
nudE neurodevelopment protein 1-like 1
|
|
NDP
|
Norrie disease (pseudoglioma)
|
|
NDUFS1
|
NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase)
|
|
NEGR1
|
neuronal growth regulator 1
|
|
NES
|
nestin
|
|
NEUROG3
|
neurogenin 3
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFIC
|
nuclear factor I/C (CCAAT-binding transcription factor)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIL1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1
|
|
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
|
|
NIPBL
|
Nipped-B homolog (Drosophila)
|
|
NISCH
|
nischarin
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NLRP2
|
NLR family, pyrin domain containing 2
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NME2
|
NME/NM23 nucleoside diphosphate kinase 2
|
|
NNMT
|
nicotinamide N-methyltransferase
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOG
|
noggin
|
|
NOS1AP
|
nitric oxide synthase 1 (neuronal) adaptor protein
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NOTCH4
|
notch 4
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NPY
|
neuropeptide Y
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2E1
|
nuclear receptor subfamily 2, group E, member 1
|
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRCAM
|
neuronal cell adhesion molecule
|
|
NRG1
|
neuregulin 1
|
|
NRGN
|
neurogranin (protein kinase C substrate, RC3)
|
|
NRP2
|
neuropilin 2
|
|
NRXN1
|
neurexin 1
|
|
NSF
|
N-ethylmaleimide-sensitive factor
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUCB2
|
nucleobindin 2
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
NUPR1
|
nuclear protein, transcriptional regulator, 1
|
|
OCA2
|
oculocutaneous albinism II
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OPCML
|
opioid binding protein/cell adhesion molecule-like
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OPTC
|
opticin
|
|
OPTN
|
optineurin
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
ORAI3
|
ORAI calcium release-activated calcium modulator 3
|
|
OSM
|
oncostatin M
|
|
OSMR
|
oncostatin M receptor
|
|
OXTR
|
oxytocin receptor
|
|
P2RX2
|
purinergic receptor P2X, ligand gated ion channel, 2
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY11
|
purinergic receptor P2Y, G-protein coupled, 11
|
|
PADI2
|
peptidyl arginine deiminase, type II
|
|
PADI3
|
peptidyl arginine deiminase, type III
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PAFAH1B1
|
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)
|
|
PAFAH2
|
platelet-activating factor acetylhydrolase 2, 40kDa
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PAM
|
peptidylglycine alpha-amidating monooxygenase
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PARP2
|
poly (ADP-ribose) polymerase 2
|
|
PAX3
|
paired box 3
|
|
PAX5
|
paired box 5
|
|
PAX9
|
paired box 9
|
|
PAXIP1
|
PAX interacting (with transcription-activation domain) protein 1
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PCDHGC3
|
protocadherin gamma subfamily C, 3
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCSK7
|
proprotein convertase subtilisin/kexin type 7
|
|
PDCD6IP
|
programmed cell death 6 interacting protein
|
|
PDCL
|
phosducin-like
|
|
PDCL3
|
phosducin-like 3
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDE6B
|
phosphodiesterase 6B, cGMP-specific, rod, beta
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDHA1
|
pyruvate dehydrogenase (lipoamide) alpha 1
|
|
PDIA2
|
protein disulfide isomerase family A, member 2
|
|
PDPN
|
podoplanin
|
|
PDYN
|
prodynorphin
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PHF6
|
PHD finger protein 6
|
|
PHLPP1
|
PH domain and leucine rich repeat protein phosphatase 1
|
|
PI4KA
|
phosphatidylinositol 4-kinase, catalytic, alpha
|
|
PIAS1
|
protein inhibitor of activated STAT, 1
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIK3C2B
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PITX3
|
paired-like homeodomain 3
|
|
PKD1L2
|
polycystic kidney disease 1-like 2 (gene/pseudogene)
|
|
PKD1L3
|
polycystic kidney disease 1-like 3
|
|
PKNOX2
|
PBX/knotted 1 homeobox 2
|
|
PKP3
|
plakophilin 3
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLXND1
|
plexin D1
|
|
PML
|
promyelocytic leukemia
|
|
PMP22
|
peripheral myelin protein 22
|
|
PNOC
|
prepronociceptin
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLE
|
polymerase (DNA directed), epsilon, catalytic subunit
|
|
POLR1B
|
polymerase (RNA) I polypeptide B, 128kDa
|
|
PON1
|
paraoxonase 1
|
|
POT1
|
protection of telomeres 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRDX4
|
peroxiredoxin 4
|
|
PREP
|
prolyl endopeptidase
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRG2
|
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
|
|
PRIMA1
|
proline rich membrane anchor 1
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKRA
|
protein kinase, interferon-inducible double stranded RNA dependent activator
|
|
PRL
|
prolactin
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROM1
|
prominin 1
|
|
PROP1
|
PROP paired-like homeobox 1
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PSG5
|
pregnancy specific beta-1-glycoprotein 5
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PSORS1C1
|
psoriasis susceptibility 1 candidate 1
|
|
PTBP1
|
polypyrimidine tract binding protein 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTN
|
pleiotrophin
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRN
|
protein tyrosine phosphatase, receptor type, N
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PTX3
|
pentraxin 3, long
|
|
RAB8A
|
RAB8A, member RAS oncogene family
|
|
RABGEF1
|
RAB guanine nucleotide exchange factor (GEF) 1
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD9A
|
RAD9 homolog A (S. pombe)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RALBP1
|
ralA binding protein 1
|
|
RANBP2
|
RAN binding protein 2
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARRES3
|
retinoic acid receptor responder (tazarotene induced) 3
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REN
|
renin
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RFXANK
|
regulatory factor X-associated ankyrin-containing protein
|
|
RGS5
|
regulator of G-protein signaling 5
|
|
RGS7
|
regulator of G-protein signaling 7
|
|
RGS9
|
regulator of G-protein signaling 9
|
|
RHCE
|
Rh blood group, CcEe antigens
|
|
RHD
|
Rh blood group, D antigen
|
|
RHO
|
rhodopsin
|
|
RHOC
|
ras homolog family member C
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
RMDN3
|
regulator of microtubule dynamics 3
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
|
RNF11
|
ring finger protein 11
|
|
RNLS
|
renalase, FAD-dependent amine oxidase
|
|
RP1
|
retinitis pigmentosa 1 (autosomal dominant)
|
|
RPS27
|
ribosomal protein S27
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RSAD2
|
radical S-adenosyl methionine domain containing 2
|
|
RTN4R
|
reticulon 4 receptor
|
|
RTP3
|
receptor (chemosensory) transporter protein 3
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX3
|
runt-related transcription factor 3
|
|
S100A10
|
S100 calcium binding protein A10
|
|
S100A13
|
S100 calcium binding protein A13
|
|
S100A14
|
S100 calcium binding protein A14
|
|
S100A2
|
S100 calcium binding protein A2
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A6
|
S100 calcium binding protein A6
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
SAA1
|
serum amyloid A1
|
|
SATB1
|
SATB homeobox 1
|
|
SCAMP2
|
secretory carrier membrane protein 2
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SCML1
|
sex comb on midleg-like 1 (Drosophila)
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCRIB
|
scribbled planar cell polarity protein
|
|
SDC1
|
syndecan 1
|
|
SELL
|
selectin L
|
|
SELPLG
|
selectin P ligand
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SEMA3D
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D
|
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F
|
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A
|
|
SENP6
|
SUMO1/sentrin specific peptidase 6
|
|
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SH2B1
|
SH2B adaptor protein 1
|
|
SH2B3
|
SH2B adaptor protein 3
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHH
|
sonic hedgehog
|
|
SHOX
|
short stature homeobox
|
|
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain
|
|
SIRT2
|
sirtuin 2
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC15A1
|
solute carrier family 15 (oligopeptide transporter), member 1
|
|
SLC15A4
|
solute carrier family 15 (oligopeptide transporter), member 4
|
|
SLC16A10
|
solute carrier family 16 (aromatic amino acid transporter), member 10
|
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SLC22A3
|
solute carrier family 22 (organic cation transporter), member 3
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SLC28A1
|
solute carrier family 28 (concentrative nucleoside transporter), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
|
SLC38A1
|
solute carrier family 38, member 1
|
|
SLC38A2
|
solute carrier family 38, member 2
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC45A2
|
solute carrier family 45, member 2
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLCO1C1
|
solute carrier organic anion transporter family, member 1C1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD4
|
SMAD family member 4
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1)
|
|
SNRNP200
|
small nuclear ribonucleoprotein 200kDa (U5)
|
|
SNRPE
|
small nuclear ribonucleoprotein polypeptide E
|
|
SOAT1
|
sterol O-acyltransferase 1
|
|
SOAT2
|
sterol O-acyltransferase 2
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SON
|
SON DNA binding protein
|
|
SOST
|
sclerostin
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPN
|
sialophorin
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPPL3
|
signal peptide peptidase like 3
|
|
SPR
|
sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SPRY4
|
sprouty homolog 4 (Drosophila)
|
|
SQSTM1
|
sequestosome 1
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SREBF2
|
sterol regulatory element binding transcription factor 2
|
|
SRGN
|
serglycin
|
|
SRPRB
|
signal recognition particle receptor, B subunit
|
|
SRRM2
|
serine/arginine repetitive matrix 2
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SSSCA1
|
Sjogren syndrome/scleroderma autoantigen 1
|
|
SSTR1
|
somatostatin receptor 1
|
|
SSTR2
|
somatostatin receptor 2
|
|
SSTR3
|
somatostatin receptor 3
|
|
SSTR5
|
somatostatin receptor 5
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
ST2
|
suppression of tumorigenicity 2
|
|
STARD4
|
StAR-related lipid transfer (START) domain containing 4
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STK17B
|
serine/threonine kinase 17b
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
STYK1
|
serine/threonine/tyrosine kinase 1
|
|
SULF1
|
sulfatase 1
|
|
SULF2
|
sulfatase 2
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SYK
|
spleen tyrosine kinase
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACR1
|
tachykinin receptor 1
|
|
TAGAP
|
T-cell activation RhoGTPase activating protein
|
|
TAGLN
|
transgelin
|
|
TALDO1
|
transaldolase 1
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAPBP
|
TAP binding protein (tapasin)
|
|
TARBP2
|
TAR (HIV-1) RNA binding protein 2
|
|
TARDBP
|
TAR DNA binding protein
|
|
TAS1R2
|
taste receptor, type 1, member 2
|
|
TAS1R3
|
taste receptor, type 1, member 3
|
|
TBX1
|
T-box 1
|
|
TCEA3
|
transcription elongation factor A (SII), 3
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCP1
|
t-complex 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFRC
|
transferrin receptor
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM2
|
transglutaminase 2
|
|
TH
|
tyrosine hydroxylase
|
|
THEM5
|
thioesterase superfamily member 5
|
|
THRB
|
thyroid hormone receptor, beta
|
|
THSD1
|
thrombospondin, type I, domain containing 1
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIRAP
|
toll-interleukin 1 receptor (TIR) domain containing adaptor protein
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR6
|
toll-like receptor 6
|
|
TLR7
|
toll-like receptor 7
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM106B
|
transmembrane protein 106B
|
|
TMEM107
|
transmembrane protein 107
|
|
TMEM18
|
transmembrane protein 18
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TMPRSS4
|
transmembrane protease, serine 4
|
|
TMSB10
|
thymosin beta 10
|
|
TMSB4X
|
thymosin beta 4, X-linked
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF19
|
tumor necrosis factor receptor superfamily, member 19
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TNFSF18
|
tumor necrosis factor (ligand) superfamily, member 18
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNIP1
|
TNFAIP3 interacting protein 1
|
|
TNIP2
|
TNFAIP3 interacting protein 2
|
|
TNIP3
|
TNFAIP3 interacting protein 3
|
|
TNNC1
|
troponin C type 1 (slow)
|
|
TNNI1
|
troponin I type 1 (skeletal, slow)
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOLLIP
|
toll interacting protein
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPCN2
|
two pore segment channel 2
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPM2
|
tropomyosin 2 (beta)
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TPSAB1
|
tryptase alpha/beta 1
|
|
TPSB2
|
tryptase beta 2 (gene/pseudogene)
|
|
TRA
|
T cell receptor alpha locus
|
|
TRAF5
|
TNF receptor-associated factor 5
|
|
TRAPPC3
|
trafficking protein particle complex 3
|
|
TRB
|
T cell receptor beta locus
|
|
TREM2
|
triggering receptor expressed on myeloid cells 2
|
|
TREX1
|
three prime repair exonuclease 1
|
|
TRMT2A
|
tRNA methyltransferase 2 homolog A (S. cerevisiae)
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPC5
|
transient receptor potential cation channel, subfamily C, member 5
|
|
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4
|
|
TRPS1
|
trichorhinophalangeal syndrome I
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSG101
|
tumor susceptibility 101
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSPO
|
translocator protein (18kDa)
|
|
TSPY1
|
testis specific protein, Y-linked 1
|
|
TTF1
|
transcription termination factor, RNA polymerase I
|
|
TTN
|
titin
|
|
TTR
|
transthyretin
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TUBB4A
|
tubulin, beta 4A class IVa
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TYMS
|
thymidylate synthetase
|
|
TYRP1
|
tyrosinase-related protein 1
|
|
UBA1
|
ubiquitin-like modifier activating enzyme 1
|
|
UBA6
|
ubiquitin-like modifier activating enzyme 6
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UFD1L
|
ubiquitin fusion degradation 1 like (yeast)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15
|
|
ULBP2
|
UL16 binding protein 2
|
|
UMPS
|
uridine monophosphate synthetase
|
|
UPK3A
|
uroplakin 3A
|
|
UQCC1
|
ubiquinol-cytochrome c reductase complex assembly factor 1
|
|
UQCC2
|
ubiquinol-cytochrome c reductase complex assembly factor 2
|
|
UQCR10
|
ubiquinol-cytochrome c reductase, complex III subunit X
|
|
UROD
|
uroporphyrinogen decarboxylase
|
|
USP2
|
ubiquitin specific peptidase 2
|
|
USP46
|
ubiquitin specific peptidase 46
|
|
UTF1
|
undifferentiated embryonic cell transcription factor 1
|
|
UTP3
|
UTP3, small subunit (SSU) processome component, homolog (S. cerevisiae)
|
|
UTRN
|
utrophin
|
|
VASH1
|
vasohibin 1
|
|
VCAN
|
versican
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIL1
|
villin 1
|
|
VIM
|
vimentin
|
|
VIP
|
vasoactive intestinal peptide
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VTN
|
vitronectin
|
|
VWF
|
von Willebrand factor
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WDR17
|
WD repeat domain 17
|
|
WDR35
|
WD repeat domain 35
|
|
WDR77
|
WD repeat domain 77
|
|
WDR83
|
WD repeat domain 83
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WNK3
|
WNK lysine deficient protein kinase 3
|
|
WNK4
|
WNK lysine deficient protein kinase 4
|
|
WNT10A
|
wingless-type MMTV integration site family, member 10A
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WSB1
|
WD repeat and SOCS box containing 1
|
|
WT1
|
Wilms tumor 1
|
|
WWC1
|
WW and C2 domain containing 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XBP1
|
X-box binding protein 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XIRP1
|
xin actin binding repeat containing 1
|
|
XPO1
|
exportin 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
YBX1
|
Y box binding protein 1
|
|
YWHAG
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZBTB7A
|
zinc finger and BTB domain containing 7A
|
|
ZCWPW1
|
zinc finger, CW type with PWWP domain 1
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZFHX3
|
zinc finger homeobox 3
|
|
ZFPM2
|
zinc finger protein, FOG family member 2
|
|
ZIC2
|
Zic family member 2
|
|
ZNF699
|
zinc finger protein 699
|
